pimavanserin



pimavanserin


SMILES CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1
InChIKey RKEWSXXUOLRFBX-UHFFFAOYSA-N

Chemical Properties

Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 8
Molecular weight (Da) 427.3

Database connections

Structure pdb 8ZMG
Ligand site mutations 5-HT2A

No bioactivity data available.

pimavanserin


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I
Phase II
Phase III
Phase IV

Database connections

Structure pdb 8ZMG
Ligand site mutations 5-HT2A

Compound is not listed as a drug.